• हिन्दी
  • ગુજરાતી
  • বাংলা
  • తెలుగు
  • मराठी
  • ಕನ್ನಡ
  • money9
  • Insurance
  • Saving
  • Mutual Funds
  • Mirae Asset MF
  • Breaking Briefs
downloadDownload The App
Close
  • Home
  • Videos
  • Podcast
  • Banking
  • Bulletin
  • Gold
  • Healthcare
  • Real Estate
  • Tax
  • Travel
  • Survey 2023
  • Survey Report
  • Breaking Briefs
  • Insurance
  • Savings
  • Loan
  • Crypto
  • Investment
  • Mutual Funds
  • Real Estate
  • Tax
  • Exclusive
  • Home » Covid-19 » Page 42

Covid 19

  • Exclusive

    PM to address medical fraternity on National Doctors' Day

    Doctors' Day is observed in honour of noted doctor and former West Bengal CM Bidhan Chandra Roy, whose birth and death anniversaries fall on July 1

  • Insurance

    Covid vaccination certificate not needed for term insurance

    All insurance companies saw an increase in Covid claims during the first two months of the financial year

  • Covid Update

    SC's financial help to kin of Covid-19 victims

    Covid-19 victims: Issue fresh guidelines within six weeks for a minimum standard of relief to be granted to families

  • Covid Update

    Covid-19: India logs 45,951 new cases, 817 fresh fatalities

    The active cases declined to 5,37,064 comprising 1.77% of the total infections, while the national Covid-19 recovery rate has improved to 96.9%

  • Investment Options

    "Rising wealth driving Indians to buy homes overseas"

    Real estate prices in the UK are near an all-time high due to the investor-friendly measures by the government like the stamp duty holiday

  • Covid Update

    Jaishankar discusses the inclusion of Covishield in EU’s Vaccination Passport with top official

    Only four vaccines- Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and, Johnson & Johnson's Janssen, have been approved by EMA.

  • Covid Update

    India’s Covaxin effectively neutralises Delta variant of Covid, says NIH

    Covaxin generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2.

  • Covid Update

    CoWIN: The ‘Made in India’ global solution

    India is at the cusp of a digital transformation and should work towards achieving the idea of 'Digital India' for the world

  • Covid Update

    AstraZeneca Covid vaccine produces stronger immune response with an 11-month gap: Study

    With a 45-week dosing interval between the first and second dose, antibody levels were four times higher than with a 12-week interval.

  • Covid Update

    Cipla gets DCGI nod to import Moderna’s Covid vaccine for restricted emergency use in India

    Moderna through a separate communication has informed that the US government has agreed to donate a certain number of doses to the Indian government.

  • ←
  • 1
  • …
  • 10

Latest

  • 1. Know the correct way to get KYC done!
  • 2. Why health insurance claim gets rejected?
  • 3. Power to Respond!
  • 4. What is Asset Under Management?
  • 5. No Worries on Medical Expenses!
  • Trending Stories

  • फर्जी कंपनी बना 22.06 करोड़ रुपये की धोखाधड़ी करने के आरोप में चार लोगों के खिलाफ प्राथमिकी
  • शीर्ष 10 मूल्यवान कंपनियों में छह का बाजार पूंजीकरण 75,257 करोड़ रुपये बढ़ा
  • मानवीय संवेदना को प्राथमिकता देते हुए भारत को एआई क्षेत्र में नेतृत्व करना चाहिए: अंबानी
  • सुस्त कामकाज के बीच तेल-तिलहन कीमतें स्थिर
  • रिजर्व बैंक ने कोटक महिंद्रा बैंक पर 62 लाख रुपये का जुर्माना लगाया
  • TV9 Sites

  • TV9 Hindi
  • TV9Telugu.com
  • TV9 Marathi
  • TV9 Gujarati
  • TV9 Kannada
  • TV9 Bangla
  • TV9 English
  • News9 Live
  • Trends9
  • Tv9tamilnews
  • Assamtv9
  • Malayalamtv9
  • Money9 Sites

  • Money9 Hindi
  • Money9 English
  • Money9 Marathi
  • Money9 Telugu
  • Money9 Gujarati
  • Money9 Kannada
  • Money9 Bangla
  • Money9live
  • Topics

  • Insurance
  • Savings
  • Loan
  • Stocks
  • Mutual Funds
  • Real Estate
  • Tax
  • Crypto
  • Exclusive
  • Follow us

  • FaceBook
  • Twitter
  • Youtube
  • Instagram
  • Linkedin
  • Download App

  • play_store
  • App_store
  • Contact Us
  • About Us
  • Advertise With Us
  • Privacy & Cookies Notice
  • Complaint Redressal
  • Copyright © 2025 Money9. All rights reserved.
  • share
  • Facebook
  • Twitter
  • Whatsapp
  • LinkedIn
  • Telegram
close